CCL22 selectively recruits CCR4+ T lymphocytes (including: Th2 and regulatory T (Treg) cells) to tumor microenvironment through the chemotaxis of CCL22/CCR4 (the receptor of CCL22)24. This evidence concerns the gene CCL22 and neoplasm.